Irving-based hormone therapy firm Biote Corp. will buy back nearly $77 million in stock to settle a lawsuit filed by the company's founder. The money will go to Gary Donovitz, who founded the company ...
Good day, and welcome to the Biote Fourth Quarter 2024 Earnings Conference Call. All participants will be in a listen-only mode. [Operator Instructions]. I would now like to turn the conference over ...
IRVING, Texas--(BUSINESS WIRE)-- Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today ...
NEW YORK, March 31, 2021 /PRNewswire/ — New research from Sciolytix proves that on-demand 3D immersive simulations are highly effective for developing the sales skills and behaviors that drive ...
IRVING, Texas--(BUSINESS WIRE)-- biote Corp., (Nasdaq: BTMD) (“Biote” or the “Company”), a high growth, differentiated medical practice-building business within the hormone optimization space, today ...
Our updated software is unique to the industry and we believe provides us with a key competitive advantage. In summary, we believe Biote has entered 2025 with a position of strength, underpinned by ...
NEW YORK, March 31, 2021 /PRNewswire/ -- New research from Sciolytix proves that on-demand 3D immersive simulations are highly effective for developing the sales skills and behaviors that drive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results